Unraveling plant natural chemical diversity for drug discovery purposes

E Lautié, O Russo, P Ducrot, JA Boutin - Frontiers in pharmacology, 2020 - frontiersin.org
The screening and testing of extracts against a variety of pharmacological targets in order to
benefit from the immense natural chemical diversity is a concern in many laboratories …

[HTML][HTML] Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance

X Liu, J Xu, J Zhou, Q Shen - Genes & diseases, 2021 - Elsevier
Cancer is one of the diseases with high morbidity and mortality on a global scale.
Chemotherapy remains the primary treatment option for most cancer patients, including …

Recent in vivo advances of spirocyclic scaffolds for drug discovery

VF Batista, DCGA Pinto, AMS Silva - Expert Opinion on Drug …, 2022 - Taylor & Francis
Introduction Spirocyclic scaffolds are an exceptional tool in drug design, allowing fine-tuning
of a molecule's conformational and physicochemical properties. As it expands and …

Diterpenoid lead stevioside and its hydrolysis products steviol and isosteviol: Biological activity and structural modification

M Wang, H Li, F Xu, X Gao, J Li, S Xu, D Zhang… - European Journal of …, 2018 - Elsevier
The diterpenoids present highly varied oxidation patterns subjected to fascinating skeletal
rearrangements, and possess antitumor, antibacterial, antihyperglycemic, anti-inflammatory …

Identification of a potent oridonin analogue for treatment of triple-negative breast cancer

H Yao, S Xie, X Ma, J Liu, H Wu, A Lin… - Journal of Medicinal …, 2020 - ACS Publications
Triple-negative breast cancer (TNBC) is one of the most highly invasive and metastatic
breast cancers without safe and effective therapeutic drugs. The natural product oridonin is …

Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells

D Luo, Y Yi, K Peng, T Liu, J Yang, S Liu… - European journal of …, 2019 - Elsevier
The biological function of the natural ent-kaurene diterpenoid isolated from genus Isodon,
oridonin, has been intensively studied. However, its mechanism studies and clinical …

The search for anticancer agents from tropical plants

JM Henkin, Y Ren, DD Soejarto… - Progress in the Chemistry …, 2018 - Springer
Many of the clinically used anticancer agents in Western medicine are derived from
secondary metabolites found in terrestrial microbes, marine organisms, and higher plants …

Hit-to-Lead Optimization of the Natural Product Oridonin as Novel NLRP3 Inflammasome Inhibitors with Potent Anti-Inflammation Activity

C He, J Liu, J Li, H Wu, C Jiao, X Ze, S Xu… - Journal of Medicinal …, 2024 - ACS Publications
Targeting NLRP3 inflammasome with inhibitors is a novel strategy for NLRP3-driven
diseases. Herein, hit compound 5 possessing an attractive skeleton was identified from our …

Diterpenoids of terrestrial origin

JR Hanson, T Nichols, Y Mukhrish… - Natural Product …, 2019 - pubs.rsc.org
Covering January to December 2017; previous review Nat. Prod. Rep., 2017, 34, 1233–
1243. This review covers the isolation and chemistry of diterpenoids from terrestrial as …

Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy – A comprehensive review

MA Ali, N Khan, A Ali, H Akram, N Zafar… - Food Science & …, 2024 - Wiley Online Library
Cancer incidences are rising each year. In 2020, approximately 20 million new cancer cases
and 10 million cancer‐related deaths were recorded. The World Health Organization (WHO) …